—Mkt Cap: —P/E: —
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source …
Industry Peers
Health Care Technologyloading…
Indicators:|
Key Statistics
Company
Market Cap—
Enterprise Value571.53M USD
Revenue (TTM)99.53M USD
Gross Profit77.22M USD
Net Income (TTM)-21.46M USD
Revenue/Share2.991 USD
Last Price—
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees220
CountryUS
SectorHealth Care
IndustryHealth Care Technology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-54.77
PEG—
EV/EBITDA-34.62
EV/Revenue5.74
P/S5.58
P/B28.71
EPS (TTM)-0.65
EPS (Forward)-0.30
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin77.23%
Oper. Margin-25.23%
EBITDA Margin-16.59%
Profit Margin-21.47%
ROE-112.79%
ROA-20.33%
Growth
Revenue Growth-2.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-11.01M USD
CapEx (TTM)332.00K USD
FCF Margin-2.75%
FCF Yield—
Net Debt16.48M USD
Net Debt/EBITDA-1.00
Balance Sheet
Debt/Equity3.72
Current Ratio5.38
Quick Ratio4.25
Book Value/Sh0.5670 USD
Cash/Share1.583 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.1 (Strong Buy)
Target (Mean)20.00 USD
Target Range18.00 USD – 22.00 USD
# Analysts8
Ownership
Shares Out.34.09M
Float23.36M
Insiders3.99%
Institutions96.30%
Short Interest
Short Ratio4.7d
Short % Float2.63%
Short % Out.2.28%
Shares Short773.85K
Short (prev mo.)948.79K
Technical
SMA 5015.38 USD
SMA 20013.59 USD
Beta1.93
S&P 52W Chg28.31%
Avg Vol (30d)—
Avg Vol (10d)246.43K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—